These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22789808)

  • 1. High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients.
    Chang YH; Chang DM; Lin KC; Hsieh CH; Lee YJ
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):751-7. PubMed ID: 22789808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients.
    Hanai K; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Bouchi R; Tanaka N; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1070-5. PubMed ID: 21785041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial.
    Araki S; Nishio Y; Araki A; Umegaki H; Sakurai T; Iimuro S; Ohashi Y; Uzu T; Maegawa H; Kashiwagi A; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():127-33. PubMed ID: 22435948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
    Kim HJ; Ahn CW; Kang ES; Myoung SM; Cha BS; Won YJ; Lim SK; Kim KR; Huh KB; Lee HC
    J Diabetes Complications; 2007; 21(1):7-12. PubMed ID: 17189868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
    Cardoso CR; Salles GF
    J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
    Nichols GA; Vupputuri S; Rosales AG
    Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients].
    Zhou Y; Guo LX; Yu DN; Zhou L; Wang Y; Mou ZQ; Wang XX; Zhang LN; Li M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jun; 33(6):610-3. PubMed ID: 22883271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL; Wu J; Guo LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year changes in biologic risk factors and risk of type 2 diabetes: are attained but not initial risk factor levels of importance?
    Gast GC; Spijkerman AM; Van der A DL; Jacobs-van der Bruggen MA; Verschuren WM
    Am J Epidemiol; 2012 Oct; 176(8):720-5. PubMed ID: 23013621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
    Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
    J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.